Business Context and Reporting Period
This Form 10-QSB covers the quarterly period ended June 30, 2003, for Orthodontix, Inc. (Note: The request metadata listed "Protalix Biotherapeutics, Inc.", but the filing text explicitly identifies the issuer as Orthodontix, Inc.). The Company is a shell entity with no current operating revenues, devoting its resources to seeking a merger or acquisition with an operating business. It has evaluated targets in aircraft maintenance, health care, pharmaceuticals, and financial services since July 2001.
Key Financial Metrics
| Metric | Q2 2003 (3 Months) | YTD 2003 (6 Months) | YTD 2002 (6 Months) |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| Net Loss | $(29,784) | $(62,271) | $(67,934) |
| Loss Per Share (Basic/Diluted) | $(0.01) | $(0.02) | $(0.02) |
| Cash and Cash Equivalents (End of Period) | $776,581 | $776,581 | $837,798 |
| Total Liabilities | $61,707 | $61,707 | $79,074 |
| Net Cash Used in Operating Activities | N/A | $(91,939) | $(97,604) |
Outstanding Shares: 2,915,428 common shares as of August 5, 2003.
Material Changes vs. Prior Period
- Net Loss Reduction: The net loss for the six months ended June 30, 2003, decreased to $62,271 from $67,934 in the same period in 2002. This improvement was driven by lower general and administrative expenses ($61,262 vs. $77,498) and a reduction in interest income ($3,241 vs. $9,252).
- Asset Realization: The Company settled a note receivable of approximately $65,000 (outstanding at Dec 31, 2002) for $60,900 in cash, recording a one-time operating expense of $4,250. This resulted in a net cash inflow from investing activities of $60,881 for the six-month period.
- Liquidity: Cash balances decreased by approximately $31,000 during the six-month period, primarily due to operating cash burn, partially offset by the collection of the note receivable.
Outlook, Risks, and Management Commentary
- Plan of Operation: Management intends to continue seeking a business combination. No contractual commitments exist for any acquisition. The Company plans to use common stock, cash, or other funding sources to effect a transaction.
- Liquidity Outlook: Management believes current cash reserves ($776,581) are sufficient to cover operating expenses for at least the next twelve months.
- Risks: There are no assurances that the Company will consummate a merger or acquisition in the near term, or on favorable terms. Even if a transaction occurs, there is no guarantee the combined entity will be profitable.
- Controls: Management concluded that disclosure controls and procedures were effective as of June 30, 2003, with no significant changes in internal controls.
Investor Verification Checklist
- Shell Status: Verify the Company has no operating revenue and relies entirely on interest income and potential acquisitions.
- Cash Runway: Confirm the $776,581 cash balance is sufficient to sustain operations for the projected 12-month period without additional capital raises.
- Acquisition Pipeline: Assess the likelihood of a merger given the lack of specific targets or binding agreements mentioned in the filing.
- Share Count: Note the static share count of 2,915,428; any future acquisition may significantly dilute existing shareholders if stock is used as currency.